Skip to Content
Søk Menu

KEYNOTE 590 – Immunterapi kan blive ny førstelinjebehandling ved avanceret esophaguscancer

Få tilgang

Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.

Relatert innhold

Live Fagereng

Necessary to Evaluate and Justify Off-Label Use of Oncology Drugs to Provide Equal Access to Effective Treatment

/ Live Fagereng
ESMO24Kreft Play the Video 2:06
Martin Højgaard

Durable Responses and Stable Disease in Multiple ATM-Altered Advanced Cancers

/ Martin Højgaard
ESMO24Kreft Play the Video 09:40

Physical Activity, Fitness, and Cardiovascular Disease Risk in Adolescent Cancer Survivors

/ Mari Bratteteig / Corina S. Rueegg / May Grydeland / Sigmund A. Anderssen / Ellen Ruud
BarnHjerte- og karsykdomKreftTrening
Christina H. Ruhlmann

Updated MASCC/ESMO Guidelines on Prevention of Cancer Therapy-Induced Nausea and Vomiting

/ Christina H. Ruhlmann
BehandlingKjemoterapiKreft Play the Video 7:41

Implementation of Early Specialized Palliative Care in an Oncologic Department

/ Katrine Rahbek Schønnemann / Sabine Ute Alice Gill
Kreft
Petter Brandal

Insights from Onkologisk Forum 2023

/ Petter Brandal
KreftOnkologiskForum23 Play the Video 5:16
Bettina Kulle Andreassen

The Value of Real-World Data in Clinical Oncological Research

/ Bettina Kulle Andreassen
KreftOnkologiskForum23 Play the Video 3:02
Petter Brandal

Proton vs Photon Radiotherapy for Brain Tumors in Patients with Diffuse Grade 2 and 3 Gliomas

/ Petter Brandal
KreftOnkologiskForum23 Play the Video 3:02
Kenneth Jensen

Proton Therapy for Head and Neck Cancer

/ Kenneth Jensen
KreftOnkologiskForum23 Play the Video 4:11
Back to top